AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 113 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q1 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,313,000 | -82.2% | 280,665 | -64.9% | 0.02% | -79.6% |
| Q2 2015 | $13,000,000 | +12.7% | 800,499 | +181.1% | 0.09% | +12.0% |
| Q1 2015 | $11,537,000 | -58.8% | 284,733 | -45.1% | 0.08% | -59.7% |
| Q4 2014 | $28,025,000 | +107.0% | 518,982 | +31.1% | 0.21% | +89.0% |
| Q3 2014 | $13,537,000 | – | 395,947 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|